[Current therapeutic strategy for rheumatoid arthritis].
The success of the treatment of rheumatoid arthritis depends primarily on early diagnosis. In most cases, basic therapy begins with methotrexate. Depending on the stage and course of the disease (radiographically detected early erosion and/or progression), basic immunosuppressive therapy can be combined or supplemented with cytokine antagonists. Furthermore, for specific indications, several alternative active substances (DMARD monotherapies) are available. Today the goal of therapy is always remission.
Wollenhaupt
J
J
Klinikum Eilbek, Hamburg. wollenhaupt@rheumatologikum.de
Alten
R
R
Burkhardt
H
H
Edelmann
E
E
Gromnica-Ihle
E
E
Krause
A
A
Krüger
K
K
Manger
B
B
Lorenz
H
H
Müller-Ladner
U
U
Nüsslein
H
H
Pott
H G
HG
Tony
H
H
Schneider
M
M
D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D003131:Combined Modality Therapy; D003245:Consensus Statements as Topic; D003299:Cooperative Behavior; D004359:Drug Therapy, Combination; D042241:Early Diagnosis; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010348:Patient Care Team; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha